We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Broad Institute Acquires License to all ChemAxon Products and Deploys Across Chemical Biology Platform


Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Broad Institute Acquires License to all ChemAxon Products and Deploys Across Chemical Biology Platform"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
 
ChemAxon announced that they have entered into an agreement with the Broad Institute of Harvard and MIT, which will license ChemAxon’s platform, discovery toolkits and desktop applications for institute-wide use. Broad will support their legacy small molecule registration system and other functionality across their Chemical Biology Platform with ChemAxon’s technology.

In addition to ChemAxon’s discovery and desktop tools, the Broad Institute has already updated their core technology for archiving small molecules by deploying the JChem platform toolkit within their existing system.

"This adoption is a part of our strategy to provide our scientists in the Chemical Biology Platform with the most modern and capable tools to accelerate our research," said Michael Foley, Director of the Broad’s Chemical Biology Platform. "The extensive capabilities of the ChemAxon software support our ongoing efforts to build and apply state of the art facilities to support our work."
Advertisement